To access this element change to forms mode OFF
Grant Award View - GA276483
Development of a Plasmodium vivax multi-analyte lateral flow assay to...
GA ID:
GA276483
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
7-Dec-2022
Publish Date:
19-Dec-2022
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2025
Value (AUD):
$1,040,534.55
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Development Grants
Grant Activity:
Development of a Plasmodium vivax multi-analyte lateral flow assay to accelerate malaria elimination
Purpose:
To efficiently eliminate Plasmodium vivax (Pv), malaria control programs require novel, easy-to-use tools to identify and treat people with hidden dormant Pv liver-stage infections. We have developed the first test to meet this requirement: a novel serological test that recognises specific patterns in a person's immune response to malaria. We are now developing a field-deployable rapid diagnostic test to ensure translation of this public health opportunity to accelerate malaria elimination.
GO ID:
GO Title:
NHMRC Development Grants 2022 for funding in 2023
Internal Reference ID:
2022/GNT2022674
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA